Trademark: 79289877
Status Date
Tuesday, July 6, 2021
Registration Number
6405774
Registration Date
Tuesday, July 6, 2021
Filing Date
Monday, January 27, 2020
Published for Opposition
Tuesday, April 20, 2021
5 Medical and veterinary preparations, namely pharmaceutical preparations for the treatment of blood disorders, blood clots and to prevent blood coagulation; pharmaceuticals, namely pharmaceutical preparations for the treatment of blood disorders, blood clots and to prevent blood coagulation; medicines, namely pharmaceutical preparations for the treatment of blood disorders; therapeutic medicines and pharmaceuticals, namely pharmaceutical preparations for the treatment of blood disorders; medical diagnostic products, namely diagnostic preparations for medical purposes; anticoagulants; anticoagulants for the treatment of medical conditions; anticoagulants for the treatment of thrombosis and blood clots; anticoagulants for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products; medicines and pharmaceuticals for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products, namely anticoagulants
40 custom manufacture of chemicals, medicines, pharmaceuticals and anticoagulants; custom manufacture of therapeutic products and medical diagnostic products in the nature of pharmaceuticals for the treatment of blood disorders, blood clots and to prevent blood coagulation; consultancy, advisory and information in connection with all of the aforementioned services, namely, providing advisory services regarding the custom manufacture of pharmaceuticals for others
42 Scientific and technological services, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; research and design in relation to science, technology, pharmaceuticals, medicine, blood, thrombosis and anticoagulants, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; preparation of scientific reports on anticoagulants for medical and veterinary purposes; engineering of medicines and pharmaceuticals; bimolecular engineering of anticoagulants, namely, the manipulation of oral small molecules for use as anticoagulants; engineering of anticoagulants; engineering of medicines and pharmaceuticals for the treatment of thrombosis and blood clotting; scientific services relating to the discovery, preclinical and clinical development of therapeutic and medical diagnostic products, namely, providing scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation; consultancy, advisory and information in connection with all of the aforementioned services, namely, advising regarding scientific research for medical purposes in the field of blood disorders, blood clots and to prevent blood coagulation
Nov 29, 2021
Final Decision Transaction Processed By Ib
Nov 9, 2021
Final Disposition Notice Sent To Ib
Nov 9, 2021
Final Disposition Processed
Oct 6, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jul 6, 2021
Registered-Principal Register
Apr 20, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 20, 2021
Published For Opposition
Apr 18, 2021
Notification Processed By Ib
Mar 31, 2021
Notification Of Possible Opposition Sent To Ib
Mar 31, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 31, 2021
Notification Of Notice Of Publication E-Mailed
Mar 12, 2021
Approved For Pub - Principal Register
Mar 11, 2021
Examiner's Amendment Entered
Mar 11, 2021
Notification Of Examiners Amendment E-Mailed
Mar 11, 2021
Examiners Amendment E-Mailed
Mar 11, 2021
Examiners Amendment -Written
Feb 25, 2021
Teas/Email Correspondence Entered
Feb 24, 2021
Correspondence Received In Law Office
Feb 24, 2021
Teas Response To Office Action Received
Sep 27, 2020
Refusal Processed By Ib
Sep 6, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 2, 2020
Refusal Processed By Mpu
Jul 28, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jul 28, 2020
Application Filing Receipt Mailed
Jul 27, 2020
Non-Final Action Written
Jul 24, 2020
Assigned To Examiner
Jul 24, 2020
New Application Office Supplied Data Entered In Tram
Jul 23, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
